19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
The US Department of Agriculture (USDA) issued a Notice of Availability and Request for Public Comme...
Read More >
Following San Francisco’s lead, California will soon significantly expand the obligation of most em...
Read More >
On September 14, 2020, Division One of the Washington Court of Appeals provided clarification in the...
Read More >
The recently enacted Setting Every Community Up for Retirement Enhancement Act of 2019 (the SECURE A...
Read More >
Seyfarth Synopsis: California’s hotly contested and closely followed AB 5 independent contractor bi...
Read More >
Following recent histrionics from the White House, ByteDance, “the Chinese internet giant that owns...
Read More >